142nd APHA Annual Meeting and Exposition

Annual Meeting Recordings are now available for purchase

311952
Mental distress severity among Florida adults: A comparison of outcomes using two measures

142nd APHA Annual Meeting and Exposition (November 15 - November 19, 2014): http://www.apha.org/events-and-meetings/annual
Monday, November 17, 2014

Tammie M. Johnson, DrPH , Department of Public Health, Brooks College of Health, University of North Florida, Jacksonville, FL
Sara McDowell, BS , Department of Public Health, University of North Florida, Jacksonville, FL
Jamie Forrest, MS , Bureau of Chronic Disease Prevention, Florida Department of Health, Tallahassee, FL
James Churilla, PhD, MPH , Department of Clinical and Applied Movement Science, University of North Florida, Jacksonville, FL
Background: Frequent mental distress (FMD) is a dichotomous variable constructed using a single core question (CQ) from the Behavioral Risk Factor Surveillance System (BRFSS) instrument and uses a cut-point of 14 out of 30 days with poor mental health. The BRFSS has an optional "Anxiety and Depression" module (ADM) that uses 8 questions about mental distress (MD) and has been used to construct a five-level MD index of severity (ADMDI).  Using FMD negates the ability to examine MD and related outcomes across a spectrum of severity. The purpose of this study is to describe the methods used for construction of a five-level MD severity index variable using responses from the single BRFSS core MD question (CQMDI) and describe the patterns of chronic disease-related outcomes by mental distress severity among Florida adults. Methods: Using data from the national 2006 BRFSS AD Module (n=170,814), the ADMDI variable was constructed in a manner consistent with the methods described in the peer-reviewed literature. The CQMDI was constructed by finding AD-analogous cut points from the CQ used to construct FMD.  The CQMDI variable was tested for reliability against the ADMDI variable and the eight questions in the AD module and found to have acceptable reliability in each comparison (Cronbach alpha values >=0.70). A descriptive analysis of FMD and CQMDI was conducted using 2010 Florida BRFSS data. Results: Using FMD, 88.2% of Florida adults have no FMD. Using the CQMDI, 79.7% of Florida adults do not have significant mental distress (CQMDI=1) and 7.2% of adults have severe mental distress (CQMDI=5). A significant proportion of adults with no FMD have some degree of mental distress and that over 60% of those with FMD have severe mental distress. Logistic regression interpretations for a number of commonly examined dependent variables varied depending on whether FMD or CQMDI is included as an independent variable. Conclusion: The CQMDI variable has acceptable reliability compared to the ADMDI variable. Using the CQMDI variable enables more frequent and more detailed examinations of health outcomes related to MD using national and state-specific BRFSS data.

Learning Areas:

Chronic disease management and prevention
Epidemiology

Learning Objectives:
Describe the process for developing a novel index of mental health severity. Describe patterns of selected outcomes using a mental distress severity index. Compare logistic regression results using a 5-level mental distress severity measure to results using a dichotomous mental distress measure.

Keyword(s): Mental Health, Epidemiology

Presenting author's disclosure statement:

Qualified on the content I am responsible for because: I have worked in the area of chronic disease epidemiology since 1998. Before entering academia in 2010, I was an epidemiologist with the Florida Department of Health. I currently am an assistant professor at the University of North Florida, Department of Public Health. I have co-authored several peer-reviewed articles on various chronic disease epidemiology topics including diabetes, tobacco use, physical activity, and metabolic syndrome.
Any relevant financial relationships? No

I agree to comply with the American Public Health Association Conflict of Interest and Commercial Support Guidelines, and to disclose to the participants any off-label or experimental uses of a commercial product or service discussed in my presentation.